H & M Hennes & Mauritz AB B (0HBP)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 176.03 |
|---|---|
| 52-week range | 156.50 – 194.00 |
| Return, 1 month / 3 months | +9.0% / +5.2% |
| Return, 1 year / 3 years | +1.7% / +37.7% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -15.7% |
| Average daily value traded | 51.50M SEK |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
H & M Hennes & Mauritz AB is a clothing retailer based in Stockholm, Sweden. It designs and sells fashion apparel, accessories, footwear and cosmetics for men, women, teenagers and children through its own stores and online channels. The group runs several brands alongside its main H&M chain, including COS, Monki, Weekday and Arket, and serves customers in many countries across Europe, the Americas, Asia and Africa. Its ranges cover everyday basics, trend-led fashion and sportswear.
The shares are listed on the London Stock Exchange in UK under the code 0HBP, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
H & M Hennes & Mauritz AB B (0HBP) trades on the London Stock Exchange in UK. It last closed at SEK 176.03 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 639 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.7% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.3% | ||
| From 52-week high | -8.5% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | -6.7% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.7% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 51.50M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +9.0% |
| 3 months | +5.2% |
| 6 months | +6.0% |
| 1 year | +1.7% |
| 3 years | +37.7% |
| 5 years | +33.6% |
Signals
| 50-day / 200-day average | 169.35 / 170.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | SEK 3.5500 |
| 6 Nov 2025 | SEK 3.4000 |
| 8 May 2025 | SEK 3.4000 |
| 7 Nov 2024 | SEK 3.2500 |
| 3 May 2024 | SEK 3.2500 |
| 9 Nov 2023 | SEK 3.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.